Literature DB >> 31976587

Regional increases in brain signal variability are associated with pain intensity reductions following repeated eccentric exercise bouts.

Jeff Boissoneault1, Landrew Sevel2, Bethany Stennett1, Meryl Alappattu3, Mark Bishop3, Michael Robinson1.   

Abstract

BACKGROUND: Traditional pain interventions limit fluctuations in pain sensation, which may paradoxically impair endogenous pain modulatory systems (EPMS). However, controlled exposures to clinically relevant pain (e.g. delayed onset muscle soreness [DOMS]) may build capacity in the EPMS. Emerging evidence suggests that regional signal variability (RSV) may be an important indicator of efficiency and modulatory capacity within brain regions. This study sought to determine the role of RSV in both susceptibility to and trainability of pain response following repeated DOMS inductions.
METHODS: Baseline and follow-up resting-state fMRI was performed on 12 healthy volunteers ~40 days apart. Between scanning visits, participants received four weekly DOMS inductions in alternating elbow flexors and were supplied seven days of post-induction pain ratings. Voxel-wise standard deviation of signal intensity was calculated to measure RSV. Associations among DOMS-related pain and RSV were assessed with regression. Relationships among baseline and change measurements were probed (i.e. susceptibility to DOMS; trainability following multiple inductions).
RESULTS: Significant association between baseline RSV in left middle frontal gyrus (MFG) and right cerebellum and reductions in DOMS-related pain unpleasantness were detected. Furthermore, increases in RSV were associated with reduced DOMS pain intensity (left lingual gyrus, right MTG, left MTG, left precuneus) and unpleasantness (left MTG, right SFG). DISCUSSION: Findings suggest that RSV may be an indicator of EPMS resilience and responsivity to training, as well as an indicator that is responsive to training. Involved regions underlie cognitive, affective and representation processes. Results further clarify the potential role of RSV as an indicator of pain modulation and resilience. SIGNIFICANCE: Regional signal variability may be an important indicator of endogenous pain modulatory system responsivity to training following repeated bouts of clinically relevant pain and may in fact be responsive to training itself.
© 2020 European Pain Federation - EFIC®.

Entities:  

Mesh:

Year:  2020        PMID: 31976587      PMCID: PMC7104905          DOI: 10.1002/ejp.1532

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  31 in total

1.  When response variability increases neural network robustness to synaptic noise.

Authors:  Gleb Basalyga; Emilio Salinas
Journal:  Neural Comput       Date:  2006-06       Impact factor: 2.026

2.  Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients.

Authors:  Donald D Price; Jason Craggs; G Nicholas Verne; William M Perlstein; Michael E Robinson
Journal:  Pain       Date:  2006-09-08       Impact factor: 6.961

3.  A component based noise correction method (CompCor) for BOLD and perfusion based fMRI.

Authors:  Yashar Behzadi; Khaled Restom; Joy Liau; Thomas T Liu
Journal:  Neuroimage       Date:  2007-05-03       Impact factor: 6.556

4.  The influence of individual motor imagery ability on cerebral recruitment during gait imagery.

Authors:  Marian van der Meulen; Gilles Allali; Sebastian W Rieger; Frédéric Assal; Patrik Vuilleumier
Journal:  Hum Brain Mapp       Date:  2012-09-27       Impact factor: 5.038

5.  Sex differences in delayed onset muscle pain.

Authors:  Erin A Dannecker; Heather A Hausenblas; Thomas W Kaminski; Michael E Robinson
Journal:  Clin J Pain       Date:  2005 Mar-Apr       Impact factor: 3.442

6.  Regional brain signal variability: a novel indicator of pain sensitivity and coping.

Authors:  Anton Rogachov; Joshua C Cheng; Nathalie Erpelding; Kasey S Hemington; Adrian P Crawley; Karen D Davis
Journal:  Pain       Date:  2016-11       Impact factor: 6.961

Review 7.  Is paradoxical pain induced by sustained opioid exposure an underlying mechanism of opioid antinociceptive tolerance?

Authors:  Tamara King; Michael H Ossipov; Todd W Vanderah; Frank Porreca; Josephine Lai
Journal:  Neurosignals       Date:  2005

8.  fMRI reveals distinct CNS processing during symptomatic and recovered complex regional pain syndrome in children.

Authors:  A Lebel; L Becerra; D Wallin; E A Moulton; S Morris; G Pendse; J Jasciewicz; M Stein; M Aiello-Lammens; E Grant; C Berde; D Borsook
Journal:  Brain       Date:  2008-06-20       Impact factor: 13.501

9.  Inter-individual differences in successful perspective taking during pain perception mediates emotional responsiveness in self and others: an fMRI study.

Authors:  Linda van der Heiden; Sigrid Scherpiet; Lilian Konicar; Niels Birbaumer; Ralf Veit
Journal:  Neuroimage       Date:  2012-10-12       Impact factor: 6.556

10.  The dark side of opioids in pain management: basic science explains clinical observation.

Authors:  Cyril Rivat; Jane Ballantyne
Journal:  Pain Rep       Date:  2016-09-08
View more
  3 in total

1.  Acute Alcohol Intake Produces Widespread Decreases in Cortical Resting Signal Variability in Healthy Social Drinkers.

Authors:  Landrew Sevel; Bethany Stennett; Victor Schneider; Nicholas Bush; Sara Jo Nixon; Michael Robinson; Jeff Boissoneault
Journal:  Alcohol Clin Exp Res       Date:  2020-06-18       Impact factor: 3.455

2.  Associations of Regional and Network Functional Connectivity With Exercise-Induced Low Back Pain.

Authors:  Nicholas J Bush; Victor Schneider; Landrew Sevel; Mark D Bishop; Jeff Boissoneault
Journal:  J Pain       Date:  2021-06-08       Impact factor: 5.383

3.  Functional Magnetic Resonance Imaging Signal Variability Is Associated With Neuromodulation in Fibromyalgia.

Authors:  Manyoel Lim; Dajung J Kim; Thiago D Nascimento; Eric Ichesco; Chelsea Kaplan; Richard E Harris; Alexandre F DaSilva
Journal:  Neuromodulation       Date:  2021-07-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.